Replacing lead in halide perovskites is of great interest due to concerns about stability and toxicity. Recently, lead free double perovskites in which the unit cell is doubled and two divalent lead cations are substituted by a combination of mono- and trivalent cations have been synthesized as bulk single crystals and as thin films. Here, we study stability and optical properties of all-inorganic cesium silver(I) bismuth(III) chloride and bromide nanocrystals with the double perovskite crystal structure. The cube-shaped nanocrystals are monodisperse in size with typical side lengths of 8 to 15 nm. The absorption spectrum of the nanocrystals presents a sharp peak, which we assign to a direct bismuth s-p transition and not to a quantum confined excitonic transition. Using this spectroscopic handle combined with high-resolution transmission electron microscopy (TEM) based elemental analysis, we conduct stoichiometric studies at the single nanocrystal level as well as decomposition assays in solution and observe that Ag diffusion and coalescence is one of the pathways by which this material degrades. Drying the nanocrystals leads to self-assembly into ordered nanocrystal solids, and these exhibit less degradation than nanocrystals in solution. Our results demonstrate that CsAgBiX (X = Cl, Br) nanocrystals are a useful model system to study structure-function relationships in the search for stable nontoxic halide perovskites.
Because of the toxicity
of lead, searching for a lead-free halide perovskite semiconducting
material with comparable optical and electronic properties is of great
interest. Rare-earth-based halide perovskite represents a promising
class of materials for this purpose. In this work, we demonstrate
the solution-phase synthesis of single-crystalline CsEuCl3 nanocrystals with a uniform size distribution centered around 15
nm. The CsEuCl3 nanocrystals have photoluminescence emission
centered at 435 nm, with a full width at half-maximum of 19 nm. Furthermore,
CsEuCl3 nanocrystals can be embedded in a polymer matrix
that provides enhanced stability under continuous laser irradiation.
Lead-free rare-earth cesium europium halide perovskite nanocrystals
represent a promising candidate to replace lead halide perovskites.
A series of homodinuclear lanthanide(III) complexes with the 4-cba ligand, [La2(4-cba)6(phen)2(H2O)6] (1) and [Ln2(4-cba)6(phen)2(H2O)2] (Ln = Pr (2), Nd (3), Sm (4), Eu (5), Gd (6), and Dy (7); 4-Hcba = 4-cyanobenzoic acid; phen = 1,10-phenanthroline), have been synthesized and structurally characterized by single-crystal X-ray diffraction. In 1, two water molecules bridge two nine-coordinated La ions, and six 4-cba ligands coordinate to the two La ions in terminal mode. In the isostructural complexes 2-7, two eight-coordinated Ln ions are connected by four bidentate 4-cba ligands, and another two 4-cba ligands terminate the two Ln ions. The variable-temperature magnetic properties of 2-7 have been investigated. Complex 7 shows a significant ferromagnetic interaction between Dy(III), while no magnetic interaction exists between Gd(III) ions in 6. In 2-5, the value of chi(M)T decreases with decreasing temperature, but the magnetic interactions between the Ln(III) ions cannot definitely be concluded. Notably, the spin-orbit coupling parameters, lambda, for Sm(III) (216(2) cm(-1)) and Eu(III) (404(2) cm(-1)) have been obtained in 4 and 5, respectively. The strong fluorescent emissions of 4, 5, and 7 demonstrate that ligand-to-Ln(III) energy transfer is efficient and that the coordinated water molecules do not quench their luminescence by the nonradiative dissipation of energy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.